These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9437625)

  • 1. Hydromorphone polymer implant. A potential alternative to methadone maintenance.
    Rhodes DJ; Grossman SA
    J Subst Abuse Treat; 1997; 14(6):535-42. PubMed ID: 9437625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
    Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
    Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification.
    Preston KL; Bigelow GE; Liebson IA
    Clin Pharmacol Ther; 1985 Aug; 38(2):219-27. PubMed ID: 2410178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diacetylmorphine versus methadone for the treatment of opioid addiction.
    Oviedo-Joekes E; Brissette S; Marsh DC; Lauzon P; Guh D; Anis A; Schechter MT
    N Engl J Med; 2009 Aug; 361(8):777-86. PubMed ID: 19692689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain.
    Lesser GJ; Grossman SA; Leong KW; Lo H; Eller S
    Pain; 1996; 65(2-3):265-72. PubMed ID: 8826516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine versus methadone maintenance for opioid dependence.
    Kosten TR; Schottenfeld R; Ziedonis D; Falcioni J
    J Nerv Ment Dis; 1993 Jun; 181(6):358-64. PubMed ID: 8501457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levo-Alpha Acetyl Methadol (LAAM). Its advantages and drawbacks.
    Finn P; Wilcock K
    J Subst Abuse Treat; 1997; 14(6):559-64. PubMed ID: 9437627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
    Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT
    J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
    Ling W; Wesson DR; Charuvastra C; Klett CJ
    Arch Gen Psychiatry; 1996 May; 53(5):401-7. PubMed ID: 8624183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limit setting on drug abuse in methadone maintenance patients.
    McCarthy JJ; Borders OT
    Am J Psychiatry; 1985 Dec; 142(12):1419-23. PubMed ID: 4073304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.
    San L; Camí J; Fernández T; Ollé JM; Peri JM; Torrens M
    Br J Addict; 1992 Jan; 87(1):55-62. PubMed ID: 1311974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Methadone maintenance.
    Lancet; 1975 Jan; 1(7900):208-9. PubMed ID: 47433
    [No Abstract]   [Full Text] [Related]  

  • 17. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance in the treatment of opioid dependence. A current perspective.
    Zweben JE; Payte JT
    West J Med; 1990 May; 152(5):588-99. PubMed ID: 2190427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal from methadone maintenance. Rate of withdrawal and expectation.
    Senay EC; Dorus W; Goldberg F; Thornton W
    Arch Gen Psychiatry; 1977 Mar; 34(3):361-7. PubMed ID: 843188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.